Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Geriatrics Reports
Erschienen in: Current Geriatrics Reports 4/2015

01.12.2015 | Geriatric Psychiatry (GT Grossberg, Section Editor)

Recent Advances in Neuromodulatory Therapies in Psychogeriatrics: From TMS to ECT to VNS to Both Surgical and Magnetic DBS

verfasst von: William Maurice Redden, Jothika Manepalli

Erschienen in: Current Geriatrics Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Neuromodulation therapies also known as brain stimulation therapies or techniques are used to treat various neuropsychiatric illnesses in adult and geriatric patients. Electroconvulsive therapy (ECT) was the first such treatment availed to be used for mood disorders and psychotic disorders. Since then, transcranial magnetic stimulation (rTMS) was also found to be effective with fewer side effects than ECT. Similarly, vagal nerve stimulation (VNS) and deep brain stimulation (DBS), used for seizure and movement disorders, respectively, have been found useful in the treatment of depression and other psychiatric disorders. These neuromodulation therapies are becoming more refined, and we are learning more about their uses in other neuropsychiatric disorders. In the last decade, there has been tremendous growth of knowledge and research in the use of these therapies, but more needs to be evaluated before such treatments become as familiar as ECT.
Literatur
1.
Olivera J, Benabarre S, Lorente T, et al. Detecting psychogeriatric problems in primary care: factors related to psychiatric symptoms in older community patients. Ment Health Fam Med. 2011;8(1):11–9.PubMedCentralPubMed
2.
Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, et al. Prevalence of depression and its treatment in an elderly population: the cache county study. Arch Gen Psychiatry. 2000;57:601–7.CrossRefPubMed
3.
Diagnosis and treatment of depression in late life. NIH consensus development conference. NIH Consens. Statement 1991 9(3):1–27.
4.
Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, et al. The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry. 2002;59:605–11.CrossRefPubMed
5.
6.
Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53.CrossRefPubMed
7.
O’Connor DW, Gardner B, Presnell I, Singh D, Tsanglis M, White E. The effectiveness of continuation-maintenance ECT in reducing depressed older patients’ hospital re-admissions. J Affect Disord. 2010;120:62–6.CrossRefPubMed
8.••
Rhebergen D, Huisman A, Bouckaert F, Kho K, Kok R, Sienaert P, et al. Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis. Am J Geriatr Psychiatr. 2015;23(3):274–82. One of the few studies in elderly ECT that shows the robust quality of ECT in achieving remission in older patients. CrossRef
9.
Burke D, Shannon J, Beveridge A. Electroconvulsive therapy use in a 97-year-old woman. Australas Psychiatr. 2007;15(5):427–30.CrossRef
10.
Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196:226–34.PubMedCentralCrossRefPubMed
11.•
Loo CK, Katalinic N, Martin D, Schweitzer I. A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis. 2012;3(2):69–85. A review of importance as it shows the benefits and ultra-brief over brief pulse in the cognitive side effects. PubMedCentralCrossRefPubMed
12.
Rapinesi C, Kotzalidis GD, Serata D, Del Casale A, Scatena P, Mazzarini L, et al. Prevention of relapse with maintenance electroconvulsive therapy in elderly patients with major depressive episode. J ECT. 2013;29:61–4.CrossRefPubMed
13.•
Nordenskjold A, von Knorring L, Ljung T, Carlborg A, Brus O, Engstrom I. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial. J ECT. 2013;29:86–92. A randomized control study that can be used by a psychiatrist as an evidence-based treatment option for M-ECT.CrossRefPubMed
14.
Van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatr. 2012;20(1):5–17.CrossRef
15.••
Aziz M, Mehringer AM, Mozurkewich E, Razik GN. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: results from a decision analytic model. Can J Psychiatry. 2005;50(7):389–97. Important as this study substantiates the effectiveness of M-ECT in preventing relapse and improving the quality of life and well being. PubMed
16.
Devanand DP, Verma AK, Tirumalasetti F, Sackeim HA. Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am Psychiatry. 1991;148(7):929–32.CrossRef
17.
Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry. 2001;158:305–8.CrossRefPubMed
18.••
Lyden H, Espinoza RT, Pirnia T, Clark K, Joshi SH, Leaver AM, et al. Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Transl Psychiatr. 2014;4:e380. An interesting original article that shows that ECT can modify dorsal fronto-limbic pathways, a step towards understanding mechanism of action of ECT. CrossRef
19.••
Regenold WT, Noorani RJ, Piez D, Patel P. Nonconvulsive electrotherapy for treatment resistant unipolar and bipolar major depressive disorder: a proof-of-concept trial. 2015. A new concept that challenges the age-old tradition of administering an adequate seizure for ECT to be effective. This opens many possibilities for clinicians who re-stimulate and/or use adjunct medication in obtaining an adequate seizure facing a risk of cognitive side effects.
20.
Raveendranathan D, Narayanaswamy JC, Reddi SV. Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur Arch Psychiatry Clin Neurosci. 2012;262(5):425–30.CrossRefPubMed
21.
Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatry. 2015;182:92.
22.
Nielsen RM, Olsen KS, Lauritsen AOE, Boesen HC. Electroconvulsive therapy as a treatment for protracted refractory delirium in the intensive care unit five cases and a review. J Crit Care. 2014;29:881.e1–881.e6.CrossRef
23.
Cumper SK, Ahle GM, Liebman LS,BA, Kellner CH. Electroconvulsive therapy (ECT) in Parkinson’s disease, ECS and dopamine enhancement. J ECT. 2014;30:122–4.CrossRefPubMed
24.
Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatr. 2012;20(1):61–72.CrossRef
25.
Acharya D, Harper DG, Achtyes ED, Seiner SJ, Mahdasian JA, Nykamp LJ, et al. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Int J Geriatr Psychiatry. 2015;30(3):265–73.CrossRefPubMed
26.
Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol. 2001;112:1367–77.CrossRefPubMed
27.
Manes F, Jorge R, Morcuende M, Yamada T, Paradiso S, Robinson RG. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr. 2001;13:225–31.CrossRefPubMed
28.
Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Muri RM, Berkhoff M, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 2004;126:123–33.CrossRefPubMed
29.
Jorge RE, Robinson RG. Treatment of late-life depression: a role of non-invasive brain stimulation techniques. Int Rev Psychiatry. 2011;23(5):437–44.PubMedCentralCrossRefPubMed
30.
Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascualr depression using repetitive transcranial magnetic stimulation. Arch Gen Psychaitry. 2008;65:268–76.CrossRef
31.•
Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry. 2003;53:324–31. Evidence that rTMS is as effective as ECT for MDD without psychosis. CrossRefPubMed
32.
Dannon PN, Dolberg OT, Schreiber S, Grunhaus L. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals-preliminary report. Biol Psychiatry. 2002;51:687–90.CrossRefPubMed
33.
Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006;117:2584–96.CrossRefPubMed
34.••
Luber B, McClintock SM, Lisanby SH. Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. Dialogues Clin Neurosci. 2013;15:87–98. An excellent overview of rTMS and MST in a geriatric population that shows potential uses in post-stroke rehabilitation, improving memory, and cognition in older patients. PubMedCentralPubMed
35.
Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. J Neurol. 2012;259:83–92.CrossRefPubMed
36.
Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study. J Neural Transm. 2013;120:813–9.CrossRefPubMed
37.•
Elder GJ, Taylor JP. Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias. Alzheimers Res Ther. 2014;6:74. An excellent review offers summary of innovative and novel approaches to improvement of cognition in dementia. The therapies are non-invasive and should be explored for clinical use. PubMedCentralCrossRefPubMed
38.
39.
40.
George MS, Sackeim HA, Rush JA, Marangell LB, Nahas Z, Husain MM, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000;47:287–95.CrossRefPubMed
41.
Rush JA, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. Biol Psychiatry. 2000;47:276–86.CrossRefPubMed
42.
Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, et al. Two-year outcome vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 2010;30:273–81.CrossRefPubMed
43.
Sjogren MJ, Hellstrom TO, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer’s disease: a pilot study. J Clin Psychiatry. 2002;63:972–80.CrossRefPubMed
44.
Merrill CA, Jonsson MA, Minthon L, Ejnell H, Silander HC, Blennow K, et al. Vagus nerve stimulation in patients with Alzheimer’s disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry. 2006;67:1171–8.CrossRefPubMed
45.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–60.CrossRefPubMed
46.
Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168(5):502–10.CrossRefPubMed
47.
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–77.CrossRefPubMed
48.
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2010;67(2):110–6.CrossRefPubMed
49.
Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer’s disease. Ann Neurol. 2010;68:521–34.CrossRefPubMed
50.
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10(2):122–6.CrossRefPubMed
51.
Turnbull IM, McGeer PL, Beattie L, Calne D, Pate B. Stimulation of the basal nucleus of meynert in senile dementia of Alzheimer’s type. A preliminary report. Appl Neurophysiol. 1985;49:216–21.
52.
Kuhn J, Hardenacke K, Lenartz D, Gruendler T, Ullsperger M, Bartsch C, et al. Deep brain stimulation of the nucleus basalis of meynert in Alzheimer’s dementia. Mol Psychiatry. 2015;20(3):353–60.CrossRefPubMed
53.
Freund HJ, Kuhn J, Lenartz D, Mai JK, Schnell T, Klosterkoetter J, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol. 2009;66(6):781–5.CrossRefPubMed
54.
Christopher PP, Leykin Y, Appelbaum PS, Holtzheimer 3rd PE, Mayberg HS, Dunn LB. Enrolling in deep brain stimulation research for depression: influences on potential subjects’ decision making. Depress Anxiety. 2012;29(2):139–46.CrossRefPubMed
55.
Synofzik M, Schlaepfer TE. Electrodes in the brain--ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders. Brain Stimul. 2011;4(1):7–16.CrossRefPubMed
Metadaten
Titel
Recent Advances in Neuromodulatory Therapies in Psychogeriatrics: From TMS to ECT to VNS to Both Surgical and Magnetic DBS
verfasst von
William Maurice Redden
Jothika Manepalli
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 4/2015
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-015-0151-8

Weitere Artikel der Ausgabe 4/2015

Current Geriatrics Reports 4/2015 Zur Ausgabe

Cardiovascular Disease in the Elderly (DE Forman, Section Editor)

Paradoxical Low Flow/Low Gradient Severe Aortic Stenosis: an Emerging Phenotype in Older Adults with Valve Disease

Cardiovascular Disease in the Elderly (DE Forman, Section Editor)

A Decision-Making Framework for Objective Risk Assessment in Older Adults with Severe Symptomatic Aortic Stenosis

Cardiovascular Disease in the Elderly (DE Forman, Section Editor)

Conundrums for Atrial Fibrillation Management in Older Adults

Cardiovascular Disease in the Elderly (DE Forman, Section Editor)

Heart Failure Among Older Adults in Skilled Nursing Facilities: More of a Dilemma Than Many Now Realize

Cardiovascular Disease in the Elderly (DE Forman, Section Editor)

The Crossroads of Geriatric Cardiology and Cardio-Oncology

Geriatric Psychiatry (GT Grossberg, Section Editor)

Current Concepts in the Diagnosis, Pathophysiology, and Treatment of Delirium: A European Perspective

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise